Announcement: Regulating the Future of Healthy Longevity Therapies
Richard Barker announced his new global working group on healthy longevity regulation during a major conference at the Lithuanian Parliament — a pivotal step in bridging innovation and policy.
Natural Therapies and Longevity Science: Towards a Healthier, Longer Life
Natural remedies and longevity science increasingly intersect. From herbs and adaptogens to lifestyle medicine, Richard Barker explores what natural therapies may contribute to a longer, healthier life.
Lithuania – from Healthspan Laggard to Leader?
How Lithuania is building a blueprint for healthy longevity — combining genomics, lifestyle medicine, and ageing science. A closer look at the country’s emerging healthspan initiatives and what they reveal about Europe’s evolving longevity landscape.
End of 2024: Reflecting on Progress and Looking Ahead to 2025
A race against time: Reflecting on progress in healthy longevity and the urgent need for breakthroughs as we look ahead to 2025.
Reflecting on 2023 and Charting the Course for 2024
Explore the global rise of healthy longevity in 2023 and what lies ahead in 2024. Prof Richard Barker discusses key trends, scientific advancements, and the future of healthspan programs.
Exploring Healthspan Opportunities and Challenges in Lithuania with Prof Richard Barker
Discover the latest insights from Prof Richard Barker on healthspan opportunities and challenges in Lithuania. Learn about key takeaways from his visits and discussions on precision prevention and innovative therapies.
Speaking at the NY Founders Forum: Precision Medicine, Longevity Science, and AI
Prof Richard Barker shares insights from the NY Founders Forum on precision medicine, longevity science, and AI. Learn about key discussions with industry leaders and innovative healthspan technologies.
The Role Of Genomics In Healthy Longevity
Discover how genomics is revolutionizing healthy longevity. Prof Richard Barker explores disease predisposition, early detection, and drug discovery through genomic insights, and discusses the future of personalized healthspan improvement.